Filing Details

Accession Number:
0001144204-13-056510
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-10-23 18:25:41
Reporting Period:
2013-10-23
Filing Date:
2013-10-23
Accepted Time:
2013-10-23 18:25:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1117480 Chimerix Inc CMRX Pharmaceutical Preparations (2834) 330903395
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1327625 P L Vii Canaan 285 Riverside Avenue, Suite 250
Westport CT 06880
Yes No Yes No
1514133 Canaan Partners Vii Llc 285 Riverside Avenue, Suite 250
Westport CT 06880
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-10-23 674,771 $15.51 2,584,990 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Footnotes
  1. The Reporting Person sold shares to the underwriters in connection with a registered public offering pursuant to the Issuer's Registration Statement on Form S-1 (No. 333-191616).
  2. Canaan Partners VII LLC (Canaan VII) is the sole General Partner of Canaan VII L.P. (together with Canaan VII, the "Canaan Entities") and each may be deemed to have sole voting and investment power over the securities held by the Reporting Person. Wende S. Hutton, a manager of Canaan VII, serves as the representative of the Canaan Entities on the Issuer's board of directors.